University of California Los Angeles /ID# 269339 — Los Angeles, California

University of California Los Angeles /ID# 269339 is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

University of California Los Angeles /ID# 269339 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Recurrent Ovarian Cancer, Folate Receptor-Alpha Positive.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of California Los Angeles /ID# 269339?

University of California Los Angeles /ID# 269339 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of California Los Angeles /ID# 269339 conducted?

University of California Los Angeles /ID# 269339 has 1 clinical trials on record, with 1 currently active. Their work covers Recurrent Ovarian Cancer, Folate Receptor-Alpha Positive.

Is University of California Los Angeles /ID# 269339 accredited by Crixeo Health?

University of California Los Angeles /ID# 269339 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of California Los Angeles /ID# 269339?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.